• LAST PRICE
    44.5400
  • TODAY'S CHANGE (%)
    Trending Up0.5000 (1.1353%)
  • Bid / Lots
    40.5400/ 1
  • Ask / Lots
    52.0000/ 2
  • Open / Previous Close
    44.7000 / 44.0400
  • Day Range
    Low 43.3000
    High 45.3200
  • 52 Week Range
    Low 9.6000
    High 48.7000
  • Volume
    390,279
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 44.04
TimeVolumeKYMR
09:32 ET367444.5501
09:36 ET190044.64
09:38 ET320044.5
09:39 ET10044.65
09:43 ET375344.14
09:45 ET380044.45
09:48 ET390044.76
09:50 ET639144.665
09:52 ET170044.5
09:54 ET390044.28
09:56 ET110044.5
09:57 ET15044.49
09:59 ET50044.38
10:01 ET112444.545
10:03 ET680044.71
10:06 ET40044.51
10:08 ET196144.27
10:10 ET243944.095
10:12 ET152844.43
10:14 ET40044.27
10:15 ET30044.17
10:19 ET71044.01
10:24 ET30043.955
10:26 ET30044.06
10:28 ET50043.84
10:32 ET270443.3
10:33 ET20043.45
10:35 ET20043.455
10:37 ET52043.57
10:39 ET230043.95
10:46 ET10043.84
10:50 ET30143.75
10:51 ET60043.64
10:53 ET40043.55
10:57 ET20043.65
11:04 ET10043.6222
11:08 ET10043.54
11:09 ET187843.755
11:11 ET20043.725
11:13 ET30043.83
11:15 ET40043.79
11:18 ET60043.67
11:20 ET50043.61
11:22 ET210043.795
11:24 ET70044.005
11:26 ET98644.14
11:27 ET512044.17
11:29 ET28044.15
11:31 ET80044.42
11:33 ET410444.47
11:36 ET62444.43
11:40 ET352044.52
11:42 ET153444.59
11:45 ET10444.66
11:47 ET58844.62
11:56 ET80044.515
11:58 ET20044.38
12:02 ET363644.605
12:03 ET60044.705
12:05 ET25044.705
12:07 ET20044.75
12:09 ET95344.74
12:12 ET50044.725
12:14 ET126444.615
12:18 ET131844.72
12:21 ET20044.65
12:30 ET40044.55
12:34 ET60044.495
12:36 ET10044.48
12:38 ET10044.44
12:41 ET202144.59
12:43 ET70044.79
12:45 ET30044.785
12:50 ET60044.615
12:52 ET40044.58
12:54 ET60044.66
12:56 ET15144.62
12:57 ET240044.78
12:59 ET130044.81
01:01 ET30044.79
01:10 ET20044.69
01:15 ET21344.69
01:17 ET10044.69
01:19 ET10044.67
01:21 ET10044.735
01:26 ET10044.68
01:30 ET129744.92
01:33 ET80044.82
01:35 ET84644.72
01:39 ET20044.69
01:42 ET40044.745
01:46 ET142945
01:48 ET90045.16
01:50 ET93945
01:51 ET20044.965
01:53 ET151745.05
01:55 ET20045.15
02:04 ET20045.13
02:06 ET10045.11
02:08 ET247845.11
02:09 ET20045.23
02:18 ET10045.18
02:20 ET340045.1
02:22 ET20045.08
02:24 ET30045.075
02:26 ET50045.095
02:27 ET60045.15
02:29 ET304545.15
02:31 ET10045.145
02:36 ET152345.04
02:38 ET482845.06
02:40 ET10045
02:42 ET50044.945
02:44 ET10044.86
02:45 ET120044.98
02:47 ET80044.91
02:49 ET10044.895
02:51 ET130045
02:54 ET80145.03
02:56 ET115244.99
02:58 ET153845
03:00 ET139944.89
03:02 ET130044.88
03:03 ET30844.84
03:05 ET90044.69
03:07 ET60044.68
03:12 ET20044.67
03:14 ET160244.955
03:16 ET60044.85
03:18 ET20044.875
03:20 ET50044.86
03:21 ET70044.82
03:23 ET70044.94
03:25 ET70045
03:27 ET180044.95
03:30 ET34244.91
03:32 ET70044.885
03:34 ET26644.9
03:36 ET50044.94
03:38 ET10044.95
03:39 ET76045
03:41 ET57644.95
03:43 ET40044.98
03:45 ET60245
03:48 ET586745
03:50 ET735644.945
03:52 ET663244.955
03:54 ET475744.8
03:56 ET398644.745
03:57 ET639744.63
03:59 ET930144.54
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKYMR
Kymera Therapeutics Inc
2.7B
-17.8x
---
United StatesRYTM
Rhythm Pharmaceuticals Inc
3.0B
-10.6x
---
United StatesPTGX
Protagonist Therapeutics Inc
2.4B
16.4x
---
United StatesAGIO
Agios Pharmaceuticals Inc
2.8B
-7.6x
---
United StatesNTLA
Intellia Therapeutics Inc
2.5B
-4.9x
---
United StatesSWTX
SpringWorks Therapeutics Inc
2.7B
-7.4x
---
As of 2024-07-26

Company Information

Kymera Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. The Company's targeted protein degradation (TPD) platform, which it refers to as Pegasus, allows it to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. It utilized its Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and it continues to apply its platform’s capabilities to additional therapeutic areas. Its clinical stage programs are IRAK4, STAT3, and MDM2, which each address high impact targets within biologically proven pathways, providing the opportunity to treat a range of immuno-inflammatory diseases, hematologic malignancies, and/or solid tumors.

Contact Information

Headquarters
500 North Beacon Street, 4Th FloorWATERTOWN, MA, United States 02472
Phone
857-285-5314
Fax
302-655-5049

Executives

Independent Chairman of the Board
Bruce Booth
President, Chief Executive Officer, Co-Founder, Director
Nello Mainolfi
Chief Financial Officer
Bruce Jacobs
Chief Operating Officer
Jeremy Chadwick
Chief Medical Officer
Jared Gollob

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.7B
Revenue (TTM)
$79.4M
Shares Outstanding
61.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.12
EPS
$-2.50
Book Value
$7.11
P/E Ratio
-17.8x
Price/Sales (TTM)
34.0
Price/Cash Flow (TTM)
---
Operating Margin
-224.19%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.